HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Burkitt's lymphoma cell line bearing surface IgA and negative for nuclear antigen of Epstein-Barr virus (EBNA).

Abstract
A new continuous cell line, TL-1, was established in tissue culture from Burkitt's lymphoma arising at the ileocecal region. It has been maintained for the past two years. The cells were small and round, and grew in a suspension culture. Population doubling time was approximately 36 hours, The cells revealed the chromosomal abnormality i.e. translocation between 8 and 14 chromosomes, which was reported on some Burkitt's lymphomas. This line was negative for nuclear antigen of EB virus (EBNA) and bore surface IgA and not any receptors. Inoculums of 10(7) cells produced tumors in the athymic nude mice. The histological appearance of the tumor was consistent with the Burkitt's lymphoma. Ultrastructural findings showed nuclear blebs and clefts. As far as we know, this was the first cell line of Burkitt's lymphoma with t(8q-; 14q+) in Japan and perhaps the first lymphoma cell line with surface IgA.
AuthorsY Hayashi, Y Matsumura, T Nishihira, I Watanabe, R Ohi, M Kasai, K Kumagai, N Kamada
JournalThe Japanese journal of experimental medicine (Jpn J Exp Med) Vol. 50 Issue 6 Pg. 423-34 (Dec 1980) ISSN: 0021-5031 [Print] Japan
PMID6268866 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Surface
  • Antigens, Viral
  • Immunoglobulin A
Topics
  • Animals
  • Antigens, Surface (analysis)
  • Antigens, Viral (analysis)
  • Burkitt Lymphoma (immunology, microbiology)
  • Cell Line
  • Cell Nucleus (immunology)
  • Cell Transformation, Viral
  • Child
  • Herpesvirus 4, Human (immunology)
  • Humans
  • Immunoglobulin A (analysis)
  • Karyotyping
  • Male
  • Mice
  • Mice, Nude
  • Neoplasm Transplantation
  • Transplantation, Heterologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: